Approvals/CIMA-AEMPS/EQUIDACENT 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

EQUIDACENT 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Centus Biotherapeutics Europe Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: bb3ddd73d7828ee9
Drug Cima Aemps Name: EQUIDACENT 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1201472001
Holder Company Name: Centus Biotherapeutics Europe Limited
Marketing Company Name: Centus Biotherapeutics Europe Limited
Authorization Date: 2020-12-28
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 25 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Centus Biotherapeutics Europe Limited

BEVACIZUMAB

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 28, 2020

Approval ID

bb3ddd73d7828ee9

Type

Standard